1. Piedimonte G, Perez MK. Respiratory syncytial virus infection and bronchiolitis. Pediatr Rev. 2014;35(12):519-530. doi:10.1542/pir.35-12-519
2. Domachowske JB, Rosenberg HF. Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. Clin Microbiol Rev. 1999;12(2):298-309.
3. Resch B. Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection. Hum Vaccin Immunother. 2017;13(9):2138-2149. doi:10.1080/21645515.2017.1337614
4. Friedman JN, Rieder MJ, Walton JM; Canadian Paediatric Society, Acute Care Committee, Drug Therapy and Hazardous Substances Committee. Bronchiolitis: recommendations for diagnosis, monitoring and management of children one to 24 months of age. Paediatr Child Health. 2014;19(9):485-498. doi:10.1093/pch/19.9.485
5. Goldstein M, Phillips R, DeVincenzo JP, et al. National Perinatal Association 2018 Respiratory Syncytial Virus (RSV) Prevention Clinical Practice Guideline: an evidence-based interdisciplinary collaboration. Neonatology Today. 2017;12:1-27.
6. European Lung Foundation. Preterm birth and the lungs. Accessed June 22, 2020. https://www.europeanlung.org/assets/files/en/publications/preterm-en.pdf
7. Sommer C, Resch B, Simões EA. Risk factors for severe respiratory syncytial virus lower respiratory tract infection. Open Microbiol J. 2011;5(suppl2-M4):144-154. doi:10.2174/1874285801105010144
8. Preterm birth. World Health Organization. Published February 19, 2018. Accessed June 23, 2020. https://www.who.int/news-room/fact-sheets/detail/preterm-birth
9. Chu HY, Tielsch J, Katz J, Magaret AS, Khatry S, LeClerq SC, et al. Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal. J Clin Virol. 2017;95:90-95. doi:10.1016/j.jcv.2017.08.017
10. Hussain M, Xu C, Lu M, Wu X, Tang L, Wu X. Wnt/β-catenin signaling links embryonic lung development and asthmatic airway remodeling. Biochim Biophys Acta Mol Basis Dis. 2017;1863(12):3226-3242. doi:10.1016/j.bbadis.2017.08.031
11. Chaw SP, Hua L, Cunningham S, Campbell H, Mikolajczyk R, Nair H; RESCEU Investigators. Respiratory syncytial virus-associated acute lower respiratory infections in children with bronchopulmonary dysplasia: systematic review and meta-analysis. J Infect Dis. doi:10.1093/infdis/jiz492
12. Greenspan JS. Bronchopulmonary dysplasia (BPD). KidsHealth from Nemours. Updated October 2014. Accessed June 24, 2020. https://kidshealth.org/en/parents/bpd.html
13. Bhandari A, Bhandari V. Pathogenesis, pathology and pathophysiology of pulmonary sequelae of bronchopulmonary dysplasia in premature infants. Front Biosci. 2003;8:e370-e380. doi:10.2741/1060
14. Use of palivizumab in children with congenital heart disease. Paediatr Child Health. 2003;8(10):631-633.